ReviewJournal of experimental & clinical cancer research : CR2022

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications.

Karama Asleh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.